Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Apr 1, 2011

Premium

Rules-Based Medicine has launched its OncologyMAP product for the quantitative measurement of 101 cancer-related proteins in serum.

RBM released the platform to a limited number of customers last October and is now making it available worldwide. The test is validated to clinical laboratory standards, which allows protein biomarker discovery research to be more easily translated to clinical trials, the company said.


Plexera this week launched its new PlexArray HT system, a label-free surface plasmon resonance-based protein interaction detection system.

According to the company, the system can analyze thousands of protein interactions in 30 minutes, using high array density sensor chips that come with multiple surface chemistries for protein, nucleic acid, small molecule, and live cell immobilization experiments.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.